Table 5b. Overall Survival Results for Muscle Invasive Bladder Cancer.
Univariate Analyses1 | Multivariate Analyses1 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Median2 | HR3 | LCL | UCL | p4 | n | Median2 | HR3 | LCL | UCL | p4 | |
Age (years) | ||||||||||||
≤ 65 | 176 | 5.3 | 1.00 | 176 | 5.1 | 1.00 | ||||||
> 65 | 248 | 3.3 | 1.41 | 1.12 | 1.77 | .004 | 248 | 3.4 | 1.38 | 1.10 | 1.74 | .006 |
Gender | ||||||||||||
Female | 130 | 2.8 | 1.00 | 130 | 2.7 | 1.00 | ||||||
Male | 297 | 4.7 | 0.70 | 0.55 | 0.88 | .002 | 294 | 4.7 | 0.68 | 0.54 | 0.86 | .002 |
Tumor Stage | ||||||||||||
T2 | 382 | 4.1 | 1.00 | 381 | 4.1 | 1.00 | ||||||
T3 or T4 | 44 | 3.7 | 1.07 | 0.75 | 1.52 | .73 | 43 | 3.5 | 1.11 | 0.76 | 1.60 | .59 |
Lymph Nodes | ||||||||||||
N0 or NX | 312 | 4.6 | 1.00 | 309 | 4.6 | 1.00 | ||||||
N1 | 115 | 2.7 | 1.40 | 1.09 | 1.81 | .008 | 115 | 2.7 | 1.40 | 1.09 | 1.80 | .009 |
ANG | ||||||||||||
0-2 | 318 | 4.1 | 1.00 | 315 | 4.0 | 1.00 | ||||||
3-4 | 35 | 2.8 | 1.26 | 0.84 | 1.88 | .26 | 35 | 3.1 | 1.20 | 0.80 | 1.80 | .37 |
MMP-2 | ||||||||||||
0-2 | 190 | 5.5 | 1.00 | 189 | 5.4 | 1.00 | ||||||
3-4 | 150 | 3.2 | 1.48 | 1.18 | 1.86 | .0008 | 148 | 3.3 | 1.44 | 1.14 | 1.83 | .003 |
5-6 | 6 | 1.9 | 2.19 | 1.38 | 3.46 | 6 | 2.0 | 2.08 | 1.29 | 3.33 | ||
p53 | ||||||||||||
0-2 | 140 | 3.2 | 1.00 | 140 | 3.3 | 1.00 | ||||||
3-4 | 186 | 4.2 | 0.84 | 0.71 | 1.00 | .05 | 183 | 4.2 | 0.86 | 0.73 | 1.02 | .09 |
5-6 | 59 | 5.6 | 0.70 | 0.50 | 0.99 | 59 | 5.2 | 0.74 | 0.53 | 1.05 | ||
Rb | ||||||||||||
0-2 | 39 | 6.5 | 1.00 | 38 | 6.6 | 1.00 | ||||||
3-4 | 311 | 3.7 | 1.43 | 1.03 | 2.00 | .03 | 309 | 3.7 | 1.48 | 1.07 | 2.03 | .02 |
5-6 | 11 | 2.1 | 2.06 | 1.06 | 4.00 | 11 | 2.1 | 2.18 | 1.15 | 4.13 | ||
PAI-1 | ||||||||||||
0-2 | 143 | 5.3 | 1.00 | 142 | 5.0 | 1.00 | ||||||
3-4 | 228 | 3.5 | 1.37 | 1.11 | 1.70 | .003 | 226 | 3.5 | 1.30 | 1.05 | 1.62 | .02 |
5-6 | 16 | 2.3 | 1.88 | 1.23 | 2.88 | 16 | 2.5 | 1.69 | 1.09 | 2.62 |
1Univariate analyses are unadjusted. Multivariate analyses are adjusted for age, sex, tumor stage, and lymph nodes.
2Median is the median years overall survival as estimated from a parametric model.
3HR is the hazard ratio from a semiparametric (Cox proportional hazards) model. The 95% confidence limits (LCL and UCL) are shown.
4The expression p-values are for trend.